Status:
COMPLETED
Hydrochlorothiazide (+) Losartan Potassium vs. Amlodipine Comparative Study (0954A-314)
Lead Sponsor:
Organon and Co
Conditions:
Essential Hypertension
Eligibility:
All Genders
20-75 years
Phase:
PHASE4
Brief Summary
An efficacy and safety study of hydrochlorothiazide (+) losartan potassium compared to amlodipine at week 12 in Korean patients with essential hypertension
Eligibility Criteria
Inclusion
- Patients of age 20 70 75 with essential hypertension
- SiDBP 90 \~ 114mmHg at V1 \& V2
Exclusion
- Patient has known or suspected secondary hypertension
- Patient has a history of malignant hypertension (SiSBP \> 210mmHg)
- Individuals has a known sensitivity or intolerance to HCTZ or any AIIAs, or any sulfonamide-derived drugs.
- Patient has shown significant abnormal laboratory evaluations
Key Trial Info
Start Date :
February 5 2005
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 8 2006
Estimated Enrollment :
174 Patients enrolled
Trial Details
Trial ID
NCT00157963
Start Date
February 5 2005
End Date
February 8 2006
Last Update
August 15 2024
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.